•  
  •  
  •  
  •  

2026-05-23 09:22:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport

Keywords Selected:  Type2Diabetes

Stock Report

  • Biocon Ltd signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
  • Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities
  • Cipla signs perpetual licensing agreement with Novartis Pharma AG for Galvus® range for diabetes therapy in India
  • Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Pvt Ltd
  • Glenmark launches Teneligliptin + Dapagliflozin Fixed Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities
  • Glenmark becomes the First to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults
  • Zydus has launched Sitaglyn® and Siglyn®, for the management of Type 2 diabetes
  • Glenmark launches Sitagliptin and its Fixed Dose Combinations
  • Glenmark to launch Drug for Type 2 Diabetes in India

Latest Post

  • Kolte-Patil Developers Ltd. Q4 & FY26 Financial Results
  • PNC Infratech Limited receives Rs. 228.90 crores based on settlement agreement from NHAI
  • NIS Management Ltd receives 5 work orders worth Rs. 30.77 crores
  • MAS Financial Services Ltd raises ₹360 Crore through NCD from FMO, the Dutch Entrepreneurial Development Bank
  • Aptus Pharma Ltd initiates brand promotion at Rajkot Hirasar Airport


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025